Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-17600CALL0 0293.5TRUE00
2025-04-17650CALL0 0170.96TRUE00
2025-04-17700CALL0 0156.01TRUE00
2025-04-17750CALL0 0142.14TRUE00
2025-04-17800CALL0 0129.18TRUE00
2025-04-17850CALL0 0117.04TRUE00
2025-04-17900CALL0 098.44TRUE00
2025-04-17950CALL0 094.8TRUE00
2025-04-1710046.95CALL0 193.62TRUE00
2025-04-171050CALL0 083.62TRUE00
2025-04-171100CALL0 074.09TRUE00
2025-04-171150CALL0 056.65TRUE00
2025-04-171200CALL0 058.94TRUE00
2025-04-1712527CALL0 8354.37TRUE00
2025-04-1713026.5CALL0 749.98TRUE00
2025-04-171353.8CALL0 42846.95TRUE00
2025-04-1714019.17CALL0 844.16TRUE00
2025-04-1714510CALL0 1044.22TRUE00
2025-04-1715017.24CALL0 140.74TRUE00
2025-04-171555.3CALL2 137.56FALSE5.30
2025-04-171603.2CALL10 10937.18FALSE-1.65-0.34
2025-04-171653.45CALL0 14345.99FALSE00
2025-04-171703.35CALL0 14243.19FALSE00
2025-04-171755.79CALL0 1253.85FALSE00
2025-04-171800.84CALL0 4158.58FALSE00
2025-04-171850.5CALL0 865.3FALSE00
2025-04-171900.8CALL0 170.52FALSE00
2025-04-171951.2CALL0 176.36FALSE00
2025-04-172000CALL0 081.48FALSE00
2025-04-172100.4CALL0 492.05FALSE00
2025-04-172200.1CALL0 12102.19FALSE00
2025-04-17600PUT0 0250.55FALSE00
2025-04-17650.4PUT0 1231.44FALSE00
2025-04-17700.25PUT0 2213.8FALSE00
2025-04-17750PUT0 0197.39FALSE00
2025-04-17800PUT0 0182.04FALSE00
2025-04-17850PUT0 0167.59FALSE00
2025-04-17900PUT0 0153.94FALSE00
2025-04-17951.05PUT0 1140.96FALSE00
2025-04-171002.5PUT0 5128.58FALSE00
2025-04-171051.08PUT0 2116.72FALSE00
2025-04-171101.18PUT0 5105.31FALSE00
2025-04-171151PUT0 4794.27FALSE00
2025-04-171207.6PUT0 1584.05FALSE00
2025-04-171255.9PUT0 6174FALSE00
2025-04-171309.74PUT0 2064.84FALSE00
2025-04-171356.07PUT0 10055.5FALSE00
2025-04-1714012.33PUT0 20049.92FALSE00
2025-04-171451.1PUT0 8239.51FALSE00
2025-04-171503.02PUT18 137.05FALSE3.020
2025-04-171555PUT30 135.46TRUE50
2025-04-171603.4PUT0 136.41TRUE00
2025-04-171650PUT0 040.42TRUE00
2025-04-171700PUT0 042.39TRUE00
2025-04-171750PUT0 043.9TRUE00
2025-04-171800PUT0 045.44TRUE00
2025-04-171850PUT0 049.14TRUE00
2025-04-171900PUT0 053.32TRUE00
2025-04-1719531.3PUT0 177.27TRUE00
2025-04-172000PUT0 065.41TRUE00
2025-04-172100PUT0 075.22TRUE00
2025-04-1722055PUT0 084.37TRUE00
2025-05-161100CALL0 051.23TRUE00
2025-05-161150CALL0 053.53TRUE00
2025-05-161200CALL0 051.97TRUE00
2025-05-161250CALL0 052.19TRUE00
2025-05-161300CALL0 050.05TRUE00
2025-05-161350CALL0 049.77TRUE00
2025-05-1614030.4CALL0 149.19TRUE00
2025-05-161450CALL0 048TRUE00
2025-05-161500CALL0 049.01TRUE00
2025-05-161550CALL0 046.91FALSE00
2025-05-161600CALL0 046.8FALSE00
2025-05-1616510.7CALL0 448.05FALSE00
2025-05-161709.3CALL0 9546.66FALSE00
2025-05-161750CALL0 048.72FALSE00
2025-05-161803.5CALL0 144.36FALSE00
2025-05-161852.95CALL0 445.84FALSE00
2025-05-161902.26CALL0 448.21FALSE00
2025-05-161950CALL0 048.23FALSE00
2025-05-162000CALL0 051.99FALSE00
2025-05-162100CALL0 057.97FALSE00
2025-05-162200CALL0 063.82FALSE00
2025-05-162300CALL0 069.15FALSE00
2025-05-162400.6CALL0 174.36FALSE00
2025-05-161100PUT0 066.75FALSE00
2025-05-161150PUT0 062.77FALSE00
2025-05-161200PUT0 057.23FALSE00
2025-05-161250PUT0 050.31FALSE00
2025-05-161300PUT0 046.2FALSE00
2025-05-161352.11PUT0 149.01FALSE00
2025-05-161402.91PUT0 148.66FALSE00
2025-05-161450PUT0 047.62FALSE00
2025-05-161500PUT0 045.69FALSE00
2025-05-161558PUT0 145.78TRUE00
2025-05-161600PUT0 045.47TRUE00
2025-05-161650PUT0 046.92TRUE00
2025-05-161700PUT0 046.9TRUE00
2025-05-161750PUT0 046.65TRUE00
2025-05-161800PUT0 045.97TRUE00
2025-05-161850PUT0 044.49TRUE00
2025-05-161900PUT0 043.89TRUE00
2025-05-161950PUT0 042.78TRUE00
2025-05-162000PUT0 043.49TRUE00
2025-05-162100PUT0 052.18TRUE00
2025-05-162200PUT0 056.02TRUE00
2025-05-162300PUT0 061.71TRUE00
2025-05-162400PUT0 067.09TRUE00
2025-06-20500CALL0 0168.24TRUE00
2025-06-20550CALL0 0154.51TRUE00
2025-06-20600CALL0 0142.12TRUE00
2025-06-20650CALL0 0130.82TRUE00
2025-06-207046CALL0 179.04TRUE00
2025-06-20750CALL0 070.33TRUE00
2025-06-20800CALL0 061.9TRUE00
2025-06-20850CALL0 053.43TRUE00
2025-06-209056.8CALL0 051.99TRUE00
2025-06-20950CALL0 039.99TRUE00
2025-06-2010047CALL0 251.92TRUE00
2025-06-2010543.6CALL0 153.61TRUE00
2025-06-201100CALL0 051.98TRUE00
2025-06-2011538.2CALL0 250.94TRUE00
2025-06-2012023.09CALL0 349.68TRUE00
2025-06-201250CALL0 049.37TRUE00
2025-06-2013041.25CALL0 948.46TRUE00
2025-06-201357.5CALL0 647.5TRUE00
2025-06-2014032CALL0 20547.03TRUE00
2025-06-2014529.15CALL0 747.05TRUE00
2025-06-2015011.93CALL0 346.73TRUE00
2025-06-201558.1CALL0 1246.79FALSE00
2025-06-201608.25CALL0 10146.57FALSE00
2025-06-201656.95CALL0 246.45FALSE00
2025-06-201700CALL0 045.78FALSE00
2025-06-201755.3CALL0 445.11FALSE00
2025-06-2018010.3CALL0 146045.1FALSE00
2025-06-201850CALL0 044.48FALSE00
2025-06-2019018.5CALL0 144.85FALSE00
2025-06-201950CALL0 045.06FALSE00
2025-06-202000CALL0 045.77FALSE00
2025-06-202100.7CALL0 148.4FALSE00
2025-06-202200CALL0 052.13FALSE00
2025-06-202300.6CALL0 754.84FALSE00
2025-06-202400.71CALL0 258.29FALSE00
2025-06-20500PUT0 0141.68FALSE00
2025-06-20550PUT0 0130.68FALSE00
2025-06-20600.25PUT0 2120.69FALSE00
2025-06-20650.3PUT0 2111.55FALSE00
2025-06-20700.45PUT0 1103.1FALSE00
2025-06-20750PUT0 095.25FALSE00
2025-06-20800PUT0 087.91FALSE00
2025-06-20850PUT0 081FALSE00
2025-06-209011.3PUT0 074.84FALSE00
2025-06-20951.4PUT0 568.96FALSE00
2025-06-201000PUT0 063.63FALSE00
2025-06-2010511PUT0 059.02FALSE00
2025-06-201104.98PUT0 154.69FALSE00
2025-06-201153.7PUT0 3050.97FALSE00
2025-06-201203.05PUT0 132046.66FALSE00
2025-06-201257.6PUT0 5045.77FALSE00
2025-06-2013010.1PUT0 2746.55FALSE00
2025-06-2013514.7PUT0 546.23FALSE00
2025-06-201405.65PUT0 20545.63FALSE00
2025-06-2014516.8PUT0 344FALSE00
2025-06-2015017.55PUT0 044.65FALSE00
2025-06-201550PUT0 044.51TRUE00
2025-06-2016013.5PUT0 344.87TRUE00
2025-06-2016515PUT0 545.63TRUE00
2025-06-201700PUT0 044.39TRUE00
2025-06-201750PUT0 044.18TRUE00
2025-06-201800PUT0 043.81TRUE00
2025-06-201850PUT0 043.6TRUE00
2025-06-201900PUT0 043.91TRUE00
2025-06-201950PUT0 042.8TRUE00
2025-06-202000PUT0 042.39TRUE00
2025-06-2021081.8PUT0 26942.92TRUE00
2025-06-202200PUT0 047.93TRUE00
2025-06-202300PUT0 050.99TRUE00
2025-06-202400PUT0 055.37TRUE00
2025-07-18700CALL0 045.26TRUE00
2025-07-18750CALL0 050.71TRUE00
2025-07-18800CALL0 062.75TRUE00
2025-07-18850CALL0 057.28TRUE00
2025-07-18900CALL0 049.34TRUE00
2025-07-18950CALL0 053.94TRUE00
2025-07-181000CALL0 054.73TRUE00
2025-07-181050CALL0 053.55TRUE00
2025-07-181100CALL0 052.03TRUE00
2025-07-181150CALL0 050.55TRUE00
2025-07-181200CALL0 050.1TRUE00
2025-07-1812523.7CALL0 349.27TRUE00
2025-07-181300CALL0 048.73TRUE00
2025-07-181350CALL0 047.78TRUE00
2025-07-181406.7CALL0 12547.16TRUE00
2025-07-181450CALL0 047.25TRUE00
2025-07-181500CALL0 047TRUE00
2025-07-181550CALL0 045.72FALSE00
2025-07-181600CALL0 046.55FALSE00
2025-07-181657.9CALL0 146.24FALSE00
2025-07-181700CALL0 045.71FALSE00
2025-07-181750CALL0 045.13FALSE00
2025-07-181804.4CALL0 144.37FALSE00
2025-07-181850CALL0 044.8FALSE00
2025-07-181900CALL0 043.8FALSE00
2025-07-181950CALL0 043.47FALSE00
2025-07-182007CALL0 15043.41FALSE00
2025-07-182102.3CALL0 244.54FALSE00
2025-07-182200CALL0 043.45FALSE00
2025-07-182300CALL0 047.85FALSE00
2025-07-182400CALL0 050.7FALSE00
2025-07-18700PUT0 089.45FALSE00
2025-07-18750PUT0 082.66FALSE00
2025-07-18800PUT0 076.68FALSE00
2025-07-18850PUT0 071.03FALSE00
2025-07-18901.16PUT0 565.97FALSE00
2025-07-18951.25PUT0 161.39FALSE00
2025-07-181001.75PUT0 557.18FALSE00
2025-07-181052.05PUT0 17555.02FALSE00
2025-07-181100PUT0 051.09FALSE00
2025-07-181150PUT0 047.14FALSE00
2025-07-181200PUT0 046.89FALSE00
2025-07-181259PUT0 146.78FALSE00
2025-07-181300PUT0 046.67FALSE00
2025-07-181350PUT0 046.21FALSE00
2025-07-181400PUT0 046.4FALSE00
2025-07-181450PUT0 044.74FALSE00
2025-07-181500PUT0 045.03FALSE00
2025-07-181550PUT0 044.19TRUE00
2025-07-181600PUT0 044.37TRUE00
2025-07-1816517.35PUT0 143.81TRUE00
2025-07-181700PUT0 043.55TRUE00
2025-07-181750PUT0 043.35TRUE00
2025-07-181800PUT0 043.09TRUE00
2025-07-181850PUT0 042.66TRUE00
2025-07-181900PUT0 043.23TRUE00
2025-07-181950PUT0 041.91TRUE00
2025-07-182000PUT0 041.8TRUE00
2025-07-182100PUT0 040.97TRUE00
2025-07-182200PUT0 044.03TRUE00
2025-07-182300PUT0 047.69TRUE00
2025-07-182400PUT0 050.18TRUE00
2025-10-17750CALL0 056.64TRUE00
2025-10-17800CALL0 049.65TRUE00
2025-10-17850CALL0 051.49TRUE00
2025-10-17900CALL0 054.43TRUE00
2025-10-17950CALL0 053.11TRUE00
2025-10-171000CALL0 052.52TRUE00
2025-10-171050CALL0 051.6TRUE00
2025-10-171100CALL0 050.86TRUE00
2025-10-171150CALL0 050.76TRUE00
2025-10-171200CALL0 050.08TRUE00
2025-10-171250CALL0 049.72TRUE00
2025-10-171300CALL0 049.31TRUE00
2025-10-171350CALL0 048.57TRUE00
2025-10-171400CALL0 049.19TRUE00
2025-10-171450CALL0 049.19TRUE00
2025-10-171500CALL0 048.99TRUE00
2025-10-171550CALL0 048.18FALSE00
2025-10-171600CALL0 047.9FALSE00
2025-10-171650CALL0 048.58FALSE00
2025-10-171700CALL0 047.71FALSE00
2025-10-171750CALL0 046.83FALSE00
2025-10-171800CALL0 047.4FALSE00
2025-10-1718516.53CALL0 146.55FALSE00
2025-10-171900CALL0 046.76FALSE00
2025-10-171950CALL0 046.12FALSE00
2025-10-172000CALL0 045.9FALSE00
2025-10-172100CALL0 045.04FALSE00
2025-10-172200CALL0 044.49FALSE00
2025-10-172300CALL0 044.41FALSE00
2025-10-172400CALL0 044.81FALSE00
2025-10-17750PUT0 063.15FALSE00
2025-10-17800PUT0 059.16FALSE00
2025-10-17850PUT0 055.57FALSE00
2025-10-17900PUT0 052.28FALSE00
2025-10-17950PUT0 049.78FALSE00
2025-10-171000PUT0 047.33FALSE00
2025-10-171050PUT0 048.29FALSE00
2025-10-171100PUT0 048.67FALSE00
2025-10-171150PUT0 048.28FALSE00
2025-10-171200PUT0 047.68FALSE00
2025-10-171257.29PUT0 248.15FALSE00
2025-10-171308.49PUT0 247.55FALSE00
2025-10-171350PUT0 047.56FALSE00
2025-10-171400PUT0 047.44FALSE00
2025-10-171450PUT0 047.33FALSE00
2025-10-171500PUT0 046.33FALSE00
2025-10-171550PUT0 046.74TRUE00
2025-10-171600PUT0 046.5TRUE00
2025-10-171650PUT0 045.43TRUE00
2025-10-171700PUT0 045.18TRUE00
2025-10-171750PUT0 045.45TRUE00
2025-10-171800PUT0 045.25TRUE00
2025-10-171850PUT0 044.93TRUE00
2025-10-171900PUT0 044.39TRUE00
2025-10-171950PUT0 044.31TRUE00
2025-10-172000PUT0 044.05TRUE00
2025-10-172100PUT0 043.13TRUE00
2025-10-172200PUT0 043.22TRUE00
2025-10-172300PUT0 042.9TRUE00
2025-10-172400PUT0 045.64TRUE00
2025-12-19600CALL0 061.65TRUE00
2025-12-19650CALL0 055.18TRUE00
2025-12-19700CALL0 054.88TRUE00
2025-12-197557.5CALL0 155.32TRUE00
2025-12-19800CALL0 056.31TRUE00
2025-12-19850CALL0 052.79TRUE00
2025-12-19900CALL0 053.38TRUE00
2025-12-19950CALL0 052.61TRUE00
2025-12-1910042.5CALL0 052.92TRUE00
2025-12-191050CALL0 051.83TRUE00
2025-12-191100CALL0 051.6TRUE00
2025-12-191150CALL0 051.38TRUE00
2025-12-1912024.2CALL0 051.57TRUE00
2025-12-1912543.45CALL0 3850.27TRUE00
2025-12-1913022CALL0 350.18TRUE00
2025-12-1913524.75CALL0 150.63TRUE00
2025-12-1914026.9CALL0 350.24TRUE00
2025-12-191450CALL0 050.18TRUE00
2025-12-1915024.8CALL0 349.4TRUE00
2025-12-1915525.63CALL0 049.55FALSE00
2025-12-1916025.2CALL3 3548.63FALSE25.20
2025-12-191650CALL0 048.62FALSE00
2025-12-1917020.5CALL0 8148.72FALSE00
2025-12-191750CALL0 047.92FALSE00
2025-12-1918012.3CALL0 1247.93FALSE00
2025-12-1918511.75CALL0 1547.53FALSE00
2025-12-1919010.75CALL0 147.29FALSE00
2025-12-1919513.85CALL0 5047.03FALSE00
2025-12-1920015CALL0 6246.98FALSE00
2025-12-1921014CALL0 1045.87FALSE00
2025-12-1922011.3CALL0 4545.96FALSE00
2025-12-192300CALL0 046.88FALSE00
2025-12-192400CALL0 046.95FALSE00
2025-12-19600PUT0 069.43FALSE00
2025-12-19650.8PUT0 164.56FALSE00
2025-12-19700PUT0 060.57FALSE00
2025-12-19750PUT0 057.27FALSE00
2025-12-19801.32PUT0 2053.85FALSE00
2025-12-19858.5PUT0 151.67FALSE00
2025-12-19902.79PUT0 2049.37FALSE00
2025-12-19950PUT0 048.65FALSE00
2025-12-191005PUT0 149.08FALSE00
2025-12-191050PUT0 049.56FALSE00
2025-12-191100PUT0 050.22FALSE00
2025-12-191150PUT0 049.62FALSE00
2025-12-1912015.5PUT0 249.33FALSE00
2025-12-1912515.5PUT0 149.15FALSE00
2025-12-1913014.3PUT0 149.66FALSE00
2025-12-1913515.25PUT0 149.25FALSE00
2025-12-191400PUT0 048.94FALSE00
2025-12-1914525.2PUT0 148.52FALSE00
2025-12-191500PUT0 048.48FALSE00
2025-12-191550PUT0 047.94TRUE00
2025-12-191600PUT0 047.3TRUE00
2025-12-191650PUT0 047.24TRUE00
2025-12-191700PUT0 047.19TRUE00
2025-12-191750PUT0 046.76TRUE00
2025-12-191800PUT0 046.55TRUE00
2025-12-1918554.71PUT0 16446.38TRUE00
2025-12-191900PUT0 046.27TRUE00
2025-12-191950PUT0 045.57TRUE00
2025-12-1920057.53PUT0 1644.9TRUE00
2025-12-1921071.8PUT0 144.5TRUE00
2025-12-1922080.5PUT0 244.25TRUE00
2025-12-192300PUT0 043.51TRUE00
2025-12-192400PUT0 043.02TRUE00
2026-01-16750CALL0 054.35TRUE00
2026-01-16800CALL0 056.57TRUE00
2026-01-16850CALL0 055.88TRUE00
2026-01-16900CALL0 055.94TRUE00
2026-01-16950CALL0 055.38TRUE00
2026-01-161000CALL0 054.41TRUE00
2026-01-161050CALL0 053.96TRUE00
2026-01-161100CALL0 053.13TRUE00
2026-01-161150CALL0 053.4TRUE00
2026-01-161200CALL0 053.22TRUE00
2026-01-161250CALL0 052.68TRUE00
2026-01-161300CALL0 052.65TRUE00
2026-01-161350CALL0 051.85TRUE00
2026-01-161400CALL0 051.02TRUE00
2026-01-161450CALL0 050.75TRUE00
2026-01-1615041CALL0 850.7TRUE00
2026-01-1615538.1CALL0 150.48FALSE00
2026-01-161600CALL0 050.12FALSE00
2026-01-1616518.2CALL0 1649.52FALSE00
2026-01-1617030.15CALL0 749.16FALSE00
2026-01-161750CALL0 049.04FALSE00
2026-01-1618019.1CALL0 448.89FALSE00
2026-01-161850CALL0 048.63FALSE00
2026-01-161900CALL0 048.19FALSE00
2026-01-161950CALL0 047.55FALSE00
2026-01-162000CALL0 048.32FALSE00
2026-01-162100CALL0 047.79FALSE00
2026-01-162200CALL0 046.79FALSE00
2026-01-162300CALL0 046.42FALSE00
2026-01-162400CALL0 046.17FALSE00
2026-01-16750PUT0 056.79FALSE00
2026-01-16800PUT0 054.08FALSE00
2026-01-16850PUT0 051.84FALSE00
2026-01-16900PUT0 051.7FALSE00
2026-01-16950PUT0 052.21FALSE00
2026-01-161000PUT0 052FALSE00
2026-01-161050PUT0 051.47FALSE00
2026-01-161100PUT0 051.64FALSE00
2026-01-161150PUT0 051.6FALSE00
2026-01-161200PUT0 051.26FALSE00
2026-01-161250PUT0 050.93FALSE00
2026-01-1613016.9PUT0 150.84FALSE00
2026-01-1613516.9PUT0 2550.3FALSE00
2026-01-1614014.6PUT0 1950.6FALSE00
2026-01-1614524.4PUT0 1450.27FALSE00
2026-01-1615021.2PUT0 149.67FALSE00
2026-01-161550PUT0 049.57TRUE00
2026-01-161600PUT0 049.57TRUE00
2026-01-1616526.5PUT0 1648.67TRUE00
2026-01-161700PUT0 048.72TRUE00
2026-01-161750PUT0 048.35TRUE00
2026-01-161800PUT0 048.2TRUE00
2026-01-161850PUT0 047.74TRUE00
2026-01-161900PUT0 047.53TRUE00
2026-01-161950PUT0 047.39TRUE00
2026-01-162000PUT0 047.21TRUE00
2026-01-162100PUT0 046.78TRUE00
2026-01-162200PUT0 046.23TRUE00
2026-01-162300PUT0 046.49TRUE00
2026-01-162400PUT0 045.91TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm